Joshua M. DeMott, PharmD, MSc, BCPS, BCCCP

About Joshua M. DeMott, PharmD, MSc, BCPS, BCCCP

Joshua M. DeMott, PharmD, MSc, BCPS, BCCCP, With an exceptional h-index of 11 and a recent h-index of 11 (since 2020), a distinguished researcher at Rush University, specializes in the field of Emergency Medicine, Health Systems Management, Critical Care.

His recent articles reflect a diverse array of research interests and contributions to the field:

Impact of Prior-to-Admission Methicillin-Resistant Staphylococcus aureus Nares Screening in Critically Ill Adults With Pneumonia

Evaluating the Risk of Developing Thrombocytopenia Within Five Days of Continuous Renal Replacement Therapy Initiation in Septic Patients

249: PRECISION DOSING AND SAFETY OF ENOXAPARIN IN HIGH-RISK PATIENTS WITH COVID-19

Under the microscope: a look into the role of critical care pharmacists during the COVID-19 pandemic

A comparison of insulin doses for treatment of hyperkalaemia in intensive care unit patients with renal insufficiency

Evaluation of the blood pressure effects of diltiazem versus metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate

Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration

Bisphosphonate versus bisphosphonate and calcitonin for the treatment of moderate to severe hypercalcemia of malignancy

Joshua M. DeMott, PharmD, MSc, BCPS, BCCCP Information

University

Position

___

Citations(all)

300

Citations(since 2020)

290

Cited By

111

hIndex(all)

11

hIndex(since 2020)

11

i10Index(all)

11

i10Index(since 2020)

11

Email

University Profile Page

Google Scholar

Joshua M. DeMott, PharmD, MSc, BCPS, BCCCP Skills & Research Interests

Emergency Medicine

Health Systems Management

Critical Care

Top articles of Joshua M. DeMott, PharmD, MSc, BCPS, BCCCP

Title

Journal

Author(s)

Publication Date

Impact of Prior-to-Admission Methicillin-Resistant Staphylococcus aureus Nares Screening in Critically Ill Adults With Pneumonia

Annals of Pharmacotherapy

Mariana G Mallidi

Giles W Slocum

Gary D Peksa

Joshua M DeMott

2022/2

Evaluating the Risk of Developing Thrombocytopenia Within Five Days of Continuous Renal Replacement Therapy Initiation in Septic Patients

Journal of Pharmacy Practice

Lauren Fay

Georgeanna Rechner-Neven

Drayton A Hammond

Joshua M DeMott

Mary Jane Sullivan

2022/2

249: PRECISION DOSING AND SAFETY OF ENOXAPARIN IN HIGH-RISK PATIENTS WITH COVID-19

Critical Care Medicine

Veronica Bonderski

Joshua DeMott

William Whittier

Nicholas Panos

Roger Rodby

...

2022/1/1

Under the microscope: a look into the role of critical care pharmacists during the COVID-19 pandemic

Payal K Gurnani

Gary D Peksa

Nicholas G Panos

Joshua M DeMott

2022/12

A comparison of insulin doses for treatment of hyperkalaemia in intensive care unit patients with renal insufficiency

Australian Critical Care

Miranda Verdier

Joshua M DeMott

Gary D Peksa

2022/5/1

Evaluation of the blood pressure effects of diltiazem versus metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate

The American Journal of Emergency Medicine

Stephany Nunez Cruz

Joshua M DeMott

Gary D Peksa

Giles W Slocum

2021/8/1

Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration

The American Journal of Emergency Medicine

Anthony J Renzoni

Gary D Peksa

Joshua M DeMott

2021/6/1

Bisphosphonate versus bisphosphonate and calcitonin for the treatment of moderate to severe hypercalcemia of malignancy

Annals of Pharmacotherapy

Attiya A Khan

Payal K Gurnani

Gary D Peksa

William L Whittier

Joshua M DeMott

2021/3

The impact of antihypertensive use in the treatment of acute ischemic stroke in patients receiving alteplase

The American Journal of Emergency Medicine

Megan A Rech

Elisabeth Donahey

Joshua M DeMott

Laura L Coles

Gary D Peksa

2021/12/1

Predictors of a response to dexmedetomidine in intubated, critically ill adult patients

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Michael A DiCesare

Megan A Rech

Joshua M DeMott

2021/2

Short versus extended duration vancomycin and piperacillin/tazobactam and the incidence of acute kidney injury in noncritically ill patients

Journal of Pharmacy Practice

Alfredo Traversa

Drayton A Hammond

Gary D Peksa

Joshua M DeMott

2021/12

Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: a systematic review and meta-analysis

Joshua M DeMott

Giles W Slocum

Michael Gottlieb

Gary D Peksa

2020/10/1

593: EFFECT OF CEFEPIME DOSAGE ON NEUROTOXICITY DEVELOPMENT IN CRITICALLY ILL ADULT PATIENTS

Critical Care Medicine

Attiya Khan

Joshua DeMott

Christy Varughese

Drayton Hammond

2020/1/1

Effect of cefepime on neurotoxicity development in critically ill adults with renal dysfunction

Chest

Attiya Khan

Joshua M DeMott

Christy Varughese

Drayton A Hammond

2020/7/1

Factors Associated with Over-Sedation Following Intubation

K Sarigiannis

JM DeMott

A Raimonde

D Khandekar

H Nizamuddin

...

2020/5

Factors associated with unsuccessful follow-up in patients undertreated for gonorrhea and chlamydia infections

The American Journal of Emergency Medicine

Jaxson Burkins

Joshua M DeMott

Giles W Slocum

Michael Gottlieb

Gary D Peksa

2020/4/1

Methicillin-Resistant Staphylococcus aureus (MRSA) nasal screen in the emergency department effect on duration of general medicine patient exposure to anti …

Rawal Medical Journal

Muhammad Asad

Mumtaz Ali Khan

A Rameez

M Tehmina

2019/12/1

Reversal of warfarin-associated major hemorrhage: activated prothrombin complex concentrate versus 4-factor prothrombin complex concentrate

Thrombosis and haemostasis

Gary D Peksa

Robert K Mokszycki

Megan A Rech

Brian Maynard

Nicholas G Panos

...

2020/2

See List of Professors in Joshua M. DeMott, PharmD, MSc, BCPS, BCCCP University(Rush University)